What are the recommended malaria chemoprophylaxis regimens for a healthy adult traveler without contraindications, including dosing and duration?

Malaria Prophylaxis for Travelers

For healthy adult travelers without contraindications, the choice of malaria chemoprophylaxis depends critically on the destination's resistance pattern: use chloroquine 300 mg base weekly for chloroquine-sensitive areas, or mefloquine, atovaquone-proguanil, or doxycycline for chloroquine-resistant regions, with mefloquine providing superior protection in high-risk chloroquine-resistant areas despite neuropsychiatric concerns. 1

Destination-Based Drug Selection

Chloroquine-Sensitive Areas

• Drug: Chloroquine 300 mg base weekly 1
• Timing: Start 1 week before travel, continue 4 weeks after return 1
• Side effects: Minor (mouth ulcers, GI upset, skin eruptions, psoriasis worsening) with rare serious effects 1
• Efficacy limitation: Poor in sub-Saharan Africa and Southeast Asia 1

Chloroquine-Resistant Areas (Limited to Moderate Resistance)

• Combination therapy: Chloroquine 300 mg base weekly PLUS proguanil 200 mg daily 1
• Protection level: Substantial but less than mefloquine 1
• Timing: Same as chloroquine monotherapy

High-Risk Chloroquine-Resistant Areas (Sub-Saharan Africa)

First-line: Mefloquine 1

• Rationale: Provides best protection despite neuropsychiatric concerns 1
• Neuropsychiatric effects: Occur in 70% within first 3 doses; severe effects in 0.01% (though British data suggests higher) 1
• Contraindications: History of convulsions, epilepsy, serious psychiatric disorder, liver impairment 1
• Caution: May impair precision movements 1

Alternatives when mefloquine unsuitable:

• Doxycycline: Second-line option 1

  • Risk: Photosensitization (uncommon but can be severe) 1
  • Avoid excessive sun exposure
  • Drug interactions: Phenytoin, carbamazepine, barbiturates shorten half-life 1

• Atovaquone-proguanil: Modern option with high compliance 2, 3

  • 97.7% compliance rate in travelers 2
  • Well-tolerated with side effects mainly in first 2 days 2

Mefloquine-Resistant Areas (Parts of Cambodia, Thailand, Myanmar)

• Drug of choice: Doxycycline 1

Universal Principles for All Chemoprophylaxis

Critical timing rules 1:

1. Start 1 week before departure - establishes habit and allows detection of side effects
2. Continue 4 weeks after return - prevents most infections
3. Compliance is essential - most deaths occur in non-compliant travelers 1

Emerging Evidence

Primaquine shows promise as alternative prophylaxis 4:

• 85-93% protective efficacy against P. falciparum and P. vivax
• Dose: 0.5 mg/kg daily (approximately 30 mg base) with food
• Advantage: Only needs continuation for 3 days after leaving malarious area
• Requirement: Normal G6PD levels, not pregnant
• Mild transient methemoglobinemia (<13%, typically <6%)

Common Pitfalls to Avoid

1. Forgetting post-travel prophylaxis: The 4-week continuation after return is when most failures occur 1
2. Assuming 100% protection: No prophylaxis provides complete protection; fever during or after travel requires urgent medical evaluation 1
3. Ignoring mosquito avoidance: Chemoprophylaxis must be combined with bite prevention (permethrin-treated nets, DEET repellent, protective clothing after sunset) 1
4. Using proguanil alone: No longer recommended due to widespread resistance 1
5. Maloprim use: Superseded by mefloquine except as second-line for Oceania; risk of agranulocytosis limits use to maximum 1 tablet weekly 1

Key Safety Considerations

The evidence consistently emphasizes that compliance determines survival more than drug choice 1. When selecting between equally effective options in chloroquine-resistant areas, consider:

• Mefloquine: Best efficacy but neuropsychiatric concerns
• Doxycycline: Photosensitivity risk
• Atovaquone-proguanil: Best tolerability and compliance but expensive 1